Company Filing History:
1 out of 4 
1 out of 84 
1 out of 44 
Years Active: 2008
Title: Gertrudis Carmeliet: Innovator in Osteoporosis Treatment
Introduction
Gertrudis Carmeliet is a prominent inventor based in Blanden, Belgium. She has made significant contributions to the field of medical research, particularly in the treatment of osteoporosis. Her innovative work focuses on the use of placental growth factor as a target for therapeutic interventions.
Latest Patents
Gertrudis Carmeliet holds a patent for "Placental growth factor as a target for the treatment of osteoporosis." This invention relates to antagonists of placental growth factor and their signaling. It includes pharmaceutical compositions containing such antagonists and their use to prevent bone loss or enhance bone healing. This work is particularly relevant for conditions that present with low bone mass and/or bone defects in vertebrates, especially in mammals, including humans. She has 1 patent to her name.
Career Highlights
Throughout her career, Gertrudis has been associated with notable institutions such as the D. Collen Research Foundation and KU Leuven Research & Development. Her research has paved the way for advancements in osteoporosis treatment, showcasing her dedication to improving health outcomes.
Collaborations
Gertrudis has collaborated with esteemed colleagues, including Peter Carmeliet and Désiré Collen. These partnerships have further enriched her research and contributed to the scientific community's understanding of bone health.
Conclusion
Gertrudis Carmeliet's innovative work in osteoporosis treatment highlights her role as a leading inventor in the medical field. Her contributions continue to impact the lives of many, demonstrating the importance of research and innovation in healthcare.